Health CanadaGeneral Alert
Pradax (dabigatran etexilate) – Updated Labelling Regarding Kidney Function Asse...
Published: March 21, 2012Recall ID: 48819Category: generalCountry: Canada
Reason for Recall / Hazard
Labelling
Product Description & Identification
Pradax (dabigatran etexilate) – Updated Labelling Regarding Kidney Function Assessment and Use in Patients with Certain Types of Heart Valve Disease or Artificial Heart Valves – For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 48819 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/pradax-dabigatran-etexilate-updated-labelling-regarding-kidney-function-assessment-0 |
| Issue | Labelling |
| Title | Pradax (dabigatran etexilate) – Updated Labelling Regarding Kidney Function Assessment and Use in Patients with Certain Types of Heart Valve Disease or Artificial Heart Valves – For the Public |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2012-03-21 |
| Organization | Marketed health products |